Video Shorts

1:11
Unpacking the NEXUS-01 Data in Bladder Cancer
4 months ago
by
Gopa Iyer, MD

1:00
RASolute 302 Read Out Marks An Exciting New Chapter in Pancreatic Cancer Care
4 months ago
by
Vincent J. Picozzi, MD

0:50
Aglatimagene Besadenovec Emerges in Prostate Cancer
4 months ago
by
Mark Garzotto, MD

1:07
Giants of Cancer Care 2026
4 months ago
by
Jonathan Lee, MD, MSc(+1 more)

3:51
Recapping the ASCO 2026 OncLive Fellows Forum: Lung Cancer
4 months ago
by
Chinmay Jani, MD

1:30
The “Million-Dollar Question”: Can Romiplostim Improve Outcomes by Maintaining Chemo Dose Intensity?
4 months ago
by
Gerald Soff, MD

0:36
An Analysis of Urinary Proteomics in Bladder Cancer
4 months ago
by
Mark Farha, MD

0:50
Investigating TTFields in Newly Diagnosed Glioblastoma
4 months ago
by
David Tran, MD, PhD

0:39
How Is AI Changing GU Cancer Surgery?
4 months ago
by
David Chen, MD

1:06
Inside the Science Behind Personalized Vaccine Development for Pancreatic Cancer
4 months ago
by
Paul E. Oberstein, MD

1:04
Previewing Updated Data From ASCENT-03 and ASCENT-04 Upcoming at ASCO 2026
4 months ago
by
Jane L. Meisel, MD

1:08
Raising Bladder Cancer Awareness
4 months ago
by
Ashish M. Kamat, MD

1:41
Previewing ASCO 2026: SUCCESSOR-2 Trial in R/R Multiple Myeloma
4 months ago
by
Rahul Banerjee, MD

3:58
OncLive News Roundup for the Week of 5/17
4 months ago
by
Chris Ryan

1:48
Previewing Key Breast Cancer Abstracts to Watch at ASCO 2026
4 months ago
by
Kevin Kalinsky, MD, MS

1:05
Breaking Down Mogamulizumab-Associated Rashes in CTCL
4 months ago
by
Stefan K. Barta, MD, MS

1:14
Previewing ASCO 2026: SENTRY, RALLY-MF Trials Represent Key MPN Abstracts
4 months ago
by
Anthony M Hunter, MD

0:54
Pancreatic Cancer Vaccines Aim to Bolster Long-Term Disease Control
4 months ago
by
Paul E. Oberstein, MD

1:27
Previewing ASCO 2026: Myeloma Abstracts to Watch
4 months ago
by
Diana Cirstea, MD

2:24
Live From AUA 2026: Interviewees Share Notable Data in GU Cancers
4 months ago
by
Kyle Doherty

1:34
Previewing ASCO 2026: Key MPN Presentations to Watch
4 months ago
by
Andrew Kuykendall, MD

0:57
What Are Experts Doing in DC Besides Attending the 2026 AUA Annual Meeting?
4 months ago
by
Kyle Doherty

0:53
Discussing Findings From a Post Hoc Analysis of DAROL in Prostate Cancer
4 months ago
by
Murilo De Almeida Luz, MD

1:00
Why There’s Still No Clear Treatment Roadmap for Treatment Sequencing in NETs
4 months ago
by
Andrew E. Hendifar, MD

0:57
Unpacking the PSA End Points of PSMAddition in Prostate Cancer
4 months ago
by
Fred Saad, CQ, MD, FRCS, FCAHS

4:10
OncLive News Roundup for the Week of 5/10
4 months ago
by
Chris Ryan(+1 more)

1:19
What Are the Biggest Unanswered Questions That Will Be Addressed at AUA 2026?
4 months ago
by
Kyle Doherty

0:59
Follow-Up After Focal Cryo-Ablation in Intermediate Favorable Risk Prostate Cancer
4 months ago
by
Herbert Lepor, MD

1:10
Highlighting the Role of Real-World Studies in Bladder Cancer
4 months ago
by
Mark D. Tyson, II, MD, MPH

0:36
Implementing a Multidisciplinary Quality Initiative in Prostate Cancer
4 months ago
by
Jason Hafron, MD
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Living Guideline for Systemic Treatment of Recurrent Ovarian Cancer
2
OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer
3
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 9/14/2026
5
